CURE staff
Articles
Three Tenets to Prevent Stivarga-Related Side Effects, Improve Survival and Quality of Life
May 28th 2021Although Stivarga may cause side effects after initial treatment, a dose escalation strategy and the preemptive use of steroid creams may help patients to tolerate the regimen better, while allowing them to capitalize on the agent’s survival benefit.
Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing
February 9th 2021CURE will host a webinar, sponsored by Amgen, in which panelists from several cancer organizations will discuss ways to improve awareness around biomarker testing, improve coordination of care for patients with lung cancer and remove barriers to access to care.
Investigational Therapy Granted Breakthrough Designation for Lung Cancer Subset
December 21st 2020The decision was based on data that demonstrated sotorasib induced anticancer activity and achieved a positive benefit-risk profile in patients with locally advanced or metastatic non-small cell lung cancer whose disease harbors a KRAS G12C mutation.
What Tips Do You Have for Coping with Roadblocks One Might Encounter on Their Cancer Journey?
August 24th 2020On social media, CURE® recently asked its readers to share some tips for others for coping with roadblocks they might experience on their cancer journey. Here, we share some of their responses.
FDA Grants Novel Treatment for Acute Myeloid Leukemia Fast Track Designation
August 5th 2020The FDA’s fast track designation for BST-236 to treat adults aged 75 years or older with acute myeloid leukemia, or who have comorbidities that prevent the use of intensive induction chemotherapy, may open the doors to an accelerated approval.
